Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody
in kidney transplant recipients with allograft dysfunction
Byung Ha Chung, Jeong Ho Kim, Bum Soon Choi, Cheol Whee Park, Ji-Il Kim, In Sung Moon, Yong-Soo Kim, Yeong Jin Choi, Eun-Jee Oh, Chul Woo Yang
Korean J Intern Med. 2018;33(1):157-167. Published online 2016 Oct 20 DOI: https://doi.org/10.3904/kjim.2016.107
Citations to this article as recorded by 
Seeking Standardized Definitions for HLA-incompatible Kidney Transplants: A Systematic Review
Sukhdeep S. Jatana, Hedi Zhao, Laurine M. Bow, Emanuele Cozzi, Ibrahim Batal, Tillie Horak, Alexandre Amar-Zifkin, Carrie Schinstock, Medhat Askar, Darshana M. Dadhania, Matthew Cooper, Maarten Naesens, Edward S. Kraus, Ruth Sapir-Pichhadze
Transplantation.2023; 107(1): 231. CrossRef
Iguratimod reduces panel reactive antibody in high mismatched renal transplant recipients: One single‐center experience
Dengyuan Feng, Zhengkai Huang, Hao Chen, Jun Tao, Xiang Gao, Jiawen Liu, Li Sun, Zijie Wang, Zhijian Han, Xiaobing Ju, Ruoyun Tan, Min Gu
Clinical Transplantation.2022;[Epub] CrossRef
De novo donor-specific HLA antibodies reduce graft survival rates and increase the risk of kidney transplant rejection: A single-center retrospective study
Wei Liu, Jie Zhao, Zhong-Yu Kang, Yan-Li Xiao, Li Yang, Chun Liu, Dai-Hong Li
Transplant Immunology.2021; 68: 101430. CrossRef
Donor-specific HLA Antibodies in Solid Organ Transplantation: Clinical Relevance and Debates
Jin Wang, Ping Wang, Shuiliang Wang, Jianming Tan
Exploratory Research and Hypothesis in Medicine.2019; 000(000): 1. CrossRef
Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
Hee-Yeon Jung, Su-Hee Kim, Min-Young Seo, Sun-Young Cho, Youngae Yang, Ji-Young Choi, Jang-Hee Cho, Sun-Hee Park, Yong-Lim Kim, Hyung-Kee Kim, Seung Huh, Dong Il Won, Chan-Duck Kim
Journal of Korean Medical Science.2018;[Epub] CrossRef